At present, it is believed that the main pathogenesis of T2DM includes insulin resistance: the main mechanisms of insulin-reducing hypoglycemia include inhibiting glucose production in liver, stimulating glucose uptake in visceral tissue (such as liver), and promoting glucose utilization in peripheral tissue (skeletal muscle and fat). This evidence concerns the gene INS and Insulin resistance.